A Patient’s Perspective on COVID-19, Obesity, and Seeking Help
OAC Vice-Chair Patty Nece, JD, shares her perspective as an individual living with obesity while navigating the COVID-19 pandemic.
Related Articles
‘Now is not the time to upend healthcare labor markets:’ AHA wants FTC noncompete proposal scrapped
The American Hospital Association has urged the Federal Trade Commission to withdraw its proposed move to ban noncompete agreements.
Philosophical Transactions of the Royal Society B: Biological Sciences: Vol 378, No 1885
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
This Consensus Report is intended to provide clinical professionals with evidence-based guidance about individualizing nutrition therapy for adults with di
Goldman Sachs Says Weight Loss Drugs Are Good For Economy, But Obesity Prevention May Be Better
GLP-1 drugs are an important tool to manage diabetes or obesity. But more resources could be spent on prevention to avoid having to treat the…
Obesity-Induced Cognitive Decline: Role of Brain Oxidation and Tocotrienols｜Shibaura Institute of Technology
SIT Shibaura Institute of Technology (Tokyo)
Cardiometabolic Improvements After Metabolic Surgery and Related Presurgery Factors
AbstractContext. Metabolic surgery remains the most effective and durable treatment for severe obesity and related metabolic diseases.Objective. We examine
U.S.-China Internet War Intensifies as House Passes TikTok Ban
The measure, which would require ByteDance to sell the popular app or stop operating in the U.S., now heads to the Senate.
Maternal obesity: sex‐specific in utero changes in fetal brain autophagy and mTOR
Objective Maternal obesity affects 39.7% of reproductive-age women in the United States. Emerging research has suggested that in utero exposure to maternal obesity is associated…
Physiology of the weight‐loss plateau in response to diet restriction, GLP‐1 receptor agonism, and bariatric surgery
Objective The objective of this study was to investigate why different weight-loss interventions result in varying durations of weight loss prior to approaching plateaus. Methods…
13 new obesity drugs could hit the market by 2029 amid surging demand (NYSE:NVO)
Drugmakers are preparing to launch an estimated 13 new weight-loss treatments in the U.S. over the next five years, according to a new report by…